FGF23 and X-linked hypophosphatemia: Among the identified hypophosphatemic disorders, X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO) are caused by persistent excess fibroblast growth factor 23 (FGF23), which leads to phosphate renal wasting and reduced phosphate availability.